Renaissance Technologies (RenTech)'s SANA Position Overview
Renaissance Technologies (RenTech) (via Renaissance Technologies LLC) currently holds 1.45 M shares of Sana Biotechnology, Inc. (SANA) worth $4.18 M, representing 0.01% of the portfolio. First purchased in 2021-Q2, this medium-term investment has been held for 20 quarters.
Based on 13F filings, Renaissance Technologies (RenTech) has maintained a strategic position in SANA, demonstrating sustained confidence in this investment. Largest addition occurred in Q3 2025, adding 1.79 M shares. Largest reduction occurred in Q4 2022, reducing 652,300 shares.
Analysis based on 13F filings available since 2013 Q2
Renaissance Technologies (RenTech)'s Sana Biotechnology (SANA) Holding Value Over Time
Track share changes against reported price movement
Quarterly Sana Biotechnology (SANA) Trades by Renaissance Technologies (RenTech)
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q1 2026 | -239,916 | Reduce 14.19% | 1.45 M | $2.88 |
| Q4 2025 | -301,384 | Reduce 15.13% | 1.69 M | $4.07 |
| Q3 2025 | +1.79 M | Add 878.10% | 1.99 M | $3.55 |
| Q2 2025 | +203,712 | New Buy | 203,712 | $2.73 |
| Q1 2025 | -319,818 | Sold Out | 0 | $0.00 |
| Q4 2024 | +303,318 | Add 1838.29% | 319,818 | $1.63 |
| Q3 2024 | -33,400 | Reduce 66.93% | 16,500 | $4.16 |
| Q2 2024 | -123,000 | Reduce 71.14% | 49,900 | $5.46 |
| Q1 2024 | -122,200 | Reduce 41.41% | 172,900 | $10.00 |
| Q4 2023 | +100,231 | Add 51.44% | 295,100 | $4.08 |
| Q3 2023 | +194,869 | New Buy | 194,869 | $3.87 |
| Q2 2023 | -61,100 | Sold Out | 0 | $0.00 |
| Q1 2023 | -104,600 | Reduce 63.13% | 61,100 | $0.01 |
| Q4 2022 | -652,300 | Reduce 79.74% | 165,700 | $0.02 |
| Q3 2022 | +31,200 | Add 3.97% | 818,000 | $6.00 |
| Q2 2022 | -53,900 | Reduce 6.41% | 786,800 | $6.43 |
| Q1 2022 | +783,400 | Add 1367.19% | 840,700 | $8.26 |
| Q4 2021 | +57,300 | New Buy | 57,300 | $15.48 |
| Q3 2021 | -22,200 | Sold Out | 0 | $0.00 |
| Q2 2021 | +22,200 | New Buy | 22,200 | $19.64 |
Renaissance Technologies (RenTech)'s Sana Biotechnology Investment FAQs
Renaissance Technologies (RenTech) first purchased Sana Biotechnology, Inc. (SANA) in Q2 2021, acquiring 22,200 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Renaissance Technologies (RenTech) has held Sana Biotechnology, Inc. (SANA) for 20 quarters since Q2 2021.
Renaissance Technologies (RenTech)'s largest addition to Sana Biotechnology, Inc. (SANA) was in Q3 2025, adding 1,992,500 shares worth $7.07 M.
According to the latest 13F filing for Q1 2026, Renaissance Technologies (RenTech)'s firm, Renaissance Technologies LLC, owns 1,451,200 shares of Sana Biotechnology, Inc. (SANA), valued at approximately $4.18 M.
As of the Q1 2026 filing, Sana Biotechnology, Inc. (SANA) represents approximately 0.01% of Renaissance Technologies (RenTech)'s publicly disclosed stock portfolio, making it one of their key holdings.
Renaissance Technologies (RenTech)'s peak holding in Sana Biotechnology, Inc. (SANA) was 1,992,500 shares, as reported at the end of Q3 2025.